Cargando…

Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers

In an attempt to improve the solubility of valsartan, a BCS II drug, fibers containing the drug were prepared from three water-soluble polymers, hydroxypropyl-methyl-cellulose (HPMC), polyvinyl-pyrrolidone (PVP), and polyvinyl-alcohol (PVA). Fiber spinning technology was optimized for each polymer s...

Descripción completa

Detalles Bibliográficos
Autores principales: Józó, Muriel, Simon, Nóra, Yi, Lan, Móczó, János, Pukánszky, Béla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780061/
https://www.ncbi.nlm.nih.gov/pubmed/35056930
http://dx.doi.org/10.3390/pharmaceutics14010034
_version_ 1784637737898344448
author Józó, Muriel
Simon, Nóra
Yi, Lan
Móczó, János
Pukánszky, Béla
author_facet Józó, Muriel
Simon, Nóra
Yi, Lan
Móczó, János
Pukánszky, Béla
author_sort Józó, Muriel
collection PubMed
description In an attempt to improve the solubility of valsartan, a BCS II drug, fibers containing the drug were prepared from three water-soluble polymers, hydroxypropyl-methyl-cellulose (HPMC), polyvinyl-pyrrolidone (PVP), and polyvinyl-alcohol (PVA). Fiber spinning technology was optimized for each polymer separately. The polymers contained 20 wt% of the active component. The drug was homogenously distributed within the fibers in the amorphous form. The presence of the drug interfered with the spinning process only slightly, the diameters of the fibers were in the same range as without the drug for the HPMC and the PVA fibers, while it doubled in PVP. The incorporation of the drug into the fibers increased its solubility in all cases compared to that of the neat drug. The solubility of the drug itself depends very much on pH and this sensitivity remained the same in the HPMC and PVP fibers; the release of the drug is dominated by the dissolution behavior of valsartan itself. On the other hand, solubility and the rate of release were practically independent of pH in the PVA fibers. The different behavior is explained by the rate of the dissolution of the respective polymer, which is larger for HPMC and PVP, and smaller for PVA than the dissolution rate of the drug. The larger extent of release compared to neat valsartan can be explained by the lack of crystallinity of the drug, its better dispersion, and the larger surface area of the fibers. Considering all facts, the preparation of electrospun devices from valsartan and water-soluble polymers is beneficial, and the use of PVA is more advantageous than that of the other two polymers.
format Online
Article
Text
id pubmed-8780061
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87800612022-01-22 Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers Józó, Muriel Simon, Nóra Yi, Lan Móczó, János Pukánszky, Béla Pharmaceutics Article In an attempt to improve the solubility of valsartan, a BCS II drug, fibers containing the drug were prepared from three water-soluble polymers, hydroxypropyl-methyl-cellulose (HPMC), polyvinyl-pyrrolidone (PVP), and polyvinyl-alcohol (PVA). Fiber spinning technology was optimized for each polymer separately. The polymers contained 20 wt% of the active component. The drug was homogenously distributed within the fibers in the amorphous form. The presence of the drug interfered with the spinning process only slightly, the diameters of the fibers were in the same range as without the drug for the HPMC and the PVA fibers, while it doubled in PVP. The incorporation of the drug into the fibers increased its solubility in all cases compared to that of the neat drug. The solubility of the drug itself depends very much on pH and this sensitivity remained the same in the HPMC and PVP fibers; the release of the drug is dominated by the dissolution behavior of valsartan itself. On the other hand, solubility and the rate of release were practically independent of pH in the PVA fibers. The different behavior is explained by the rate of the dissolution of the respective polymer, which is larger for HPMC and PVP, and smaller for PVA than the dissolution rate of the drug. The larger extent of release compared to neat valsartan can be explained by the lack of crystallinity of the drug, its better dispersion, and the larger surface area of the fibers. Considering all facts, the preparation of electrospun devices from valsartan and water-soluble polymers is beneficial, and the use of PVA is more advantageous than that of the other two polymers. MDPI 2021-12-24 /pmc/articles/PMC8780061/ /pubmed/35056930 http://dx.doi.org/10.3390/pharmaceutics14010034 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Józó, Muriel
Simon, Nóra
Yi, Lan
Móczó, János
Pukánszky, Béla
Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers
title Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers
title_full Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers
title_fullStr Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers
title_full_unstemmed Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers
title_short Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers
title_sort improved release of a drug with poor water solubility by using electrospun water-soluble polymers as carriers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780061/
https://www.ncbi.nlm.nih.gov/pubmed/35056930
http://dx.doi.org/10.3390/pharmaceutics14010034
work_keys_str_mv AT jozomuriel improvedreleaseofadrugwithpoorwatersolubilitybyusingelectrospunwatersolublepolymersascarriers
AT simonnora improvedreleaseofadrugwithpoorwatersolubilitybyusingelectrospunwatersolublepolymersascarriers
AT yilan improvedreleaseofadrugwithpoorwatersolubilitybyusingelectrospunwatersolublepolymersascarriers
AT moczojanos improvedreleaseofadrugwithpoorwatersolubilitybyusingelectrospunwatersolublepolymersascarriers
AT pukanszkybela improvedreleaseofadrugwithpoorwatersolubilitybyusingelectrospunwatersolublepolymersascarriers